[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

about

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

Item

http://www.wikidata.org/entity/Q55447089

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@en

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@nl

type

Item

label

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@en

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@nl

prefLabel

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@en

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@nl

P1476

[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].

@en

P2093

Baolan Li

http://www.w3.org/2001/XMLSchema#string

Hongmei Zhang

http://www.w3.org/2001/XMLSchema#string

Hua Zheng

http://www.w3.org/2001/XMLSchema#string

Li Tong

http://www.w3.org/2001/XMLSchema#string

Weihua Wu

http://www.w3.org/2001/XMLSchema#string

Ying Hu

http://www.w3.org/2001/XMLSchema#string

P2860

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule.

[Efficacy study of single-agent gemcitabine versus gemcitabine plus carboplatin in untreated elderly patients with stage IIIb/IV non-small-cell lung cancer].

Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?

Non-small-cell lung cancer in the elderly.

The new lung cancer staging system.

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.

A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.

P304

502-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2011.06.05

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21645453

http://www.w3.org/2001/XMLSchema#string

P932

5999885

http://www.w3.org/2001/XMLSchema#string